Blast Crisis of Ph-Positive Chronic Myeloid Leukemia with Isochromosome 17q: Report of 12 Cases and Review of the Literature

References

• Koeffler H. P., Golde D. W. Chronic myeloge-nous leukemia-new concepts. N. Engl. J. Med. 1981; 304: 1201–1209
   PubMed Web of Science ®Google Scholar
• Cervantes E., Ballesta F., Milá M., Rozman C. Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: results and prognostic evaluation in 52 patients. Cancer Genet. Cytogenet. 1986; 21: 239–246
   PubMed Web of Science ®Google Scholar
• Alimena G., De Cuia M. R., Diverio D., Gastaldi R., Nanni M. The karyotype of blastic crisis. Cancer Genet. Cytogener. 1987; 26: 39–50
   PubMed Web of Science ®Google Scholar
• Bernstein R. Cytogenetics of chronic myelogenous leukemia. Sem. Hematol. 1988; 25: 20–34
   PubMed Web of Science ®Google Scholar
• Mitelman F., Brandt L., Levan G. Identification of isochromosome 17 in acute myeloid leukemia. Lancet 1973; 27: 972
   Google Scholar
• Weh H. J., Kuse R., Hossfeld D. K. Acute nonl-ymphocytic leukemia (ANLL) with isochromosome i(17q) as the sole chromosomal anomaly: a distinct entity?. Eur: J. Haematol. 1990; 44: 312–314
   PubMed Web of Science ®Google Scholar
• Sandberg A. A. The chromosomes in human cancer and leukemia. Elsevier, New York 1980
   Google Scholar
• Mitelman E. Catalogue of chromosome aberrations in cancer4^th edn. AR Liss, New York 1991
   Google Scholar
• McCrure R. F., Dewald G. W., Hoyer J. D., Hanson C. A. Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course. Br. J Haematol. 1999; 106: 445–454
   PubMed Web of Science ®Google Scholar
• Ahuja H. G., Bar-Eli M., Arlin Z., Advani S., Allen S. L., Goldman J., Snyder D., Foti A., Cline M. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest. 1991; 87: 2042–2047
   PubMed Web of Science ®Google Scholar
• Human Gene Mapping 8. Eighth International Workshop on Human Gene Mapping. Cytogenet. Cell. Genet. 1985; 40: 490–535
   PubMedGoogle Scholar
• Rovira A., Urbano-Ispizua A., Cervantes F., Rozman M., Vives-Corrons J. L., Montserrat E., Rozman C. p53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study. Ann. Hematol. 1995; 70: 129–133
   PubMed Web of Science ®Google Scholar
• Nakai H., Misawa S. Chromosome 17 abnormalities and inactivation of the p53 gene in chronic myeloid leukemia and their prognostic significance. Leuk. Lymphoma 1995; 19: 213–221
   PubMed Web of Science ®Google Scholar
• First International Workshop on Chromosomes in Leukaemia Chromosomes in Ph-positive chronic granulocytic leukaemia. Br: J. Haematol. 1978; 39: 305–309
   PubMed Web of Science ®Google Scholar
• Lilleyman J. S., Potter A. M., Watmore A. E., Cooke P., Sokol R. J., Wood J. K. Myeloid karyotype and the malignant phase of chronic granulocytic leukaemia. B: J. Haematol. 1978; 39: 317–323
   PubMed Web of Science ®Google Scholar
• Kohno S., Sandberg A. A. Chromosomes and causation of human cancer and leukemia: XXXIX. Usual and unusual findings in Ph-positive CML. Cancer 1980; 46: 2227–2231
   PubMed Web of Science ®Google Scholar
• Fleischman E. W., Prigogina E. L., Volkova M. A., Frenkel M. A., Zakhartchenko N. A., Konstantinova L. N., Puchkova G. P., Balakirev S. A. Correlations between the clinical course, characteristics of the blast cells, and karyotype patterns in chronic myeloid leukemia. Hum. Genet. 1981; 58: 285–293
   PubMed Web of Science ®Google Scholar
• Alimena G., Dallapiccola B., Gastaldi R., Mandelli F., Brandt L., Mitelman E., Nilsson P. G. Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia. A study of 69 cases. Scand. J. Haematol. 1982; 28: 103–117
   PubMedGoogle Scholar
• Borgström G. H., Vuopio P., de la Chapelle A. Abnormalities of chromosome No. 17 in myeloproliferative disorders. Cancer Genet. Cytogenet. 1982; 5: 123–135
   PubMed Web of Science ®Google Scholar
• Ishihara T., Sasaki M., Oshimura M., Kamada N., Yamada K., Okada M., Sakurai M., Sugiyama T., Shiraishi Y., Kohno S. A summary of cytogenetic studies on 534 cases of chronic myelocytic leukemia in Japan. Cancer Genet. Cytogenet. 1983; 9: 81–92
   PubMed Web of Science ®Google Scholar
• Sadamori N., Matsunaga M., Yao E., Ichimaru M., Sandberg A. A. Chromosomal characteristics of chronic and blastic phases of Ph-positive chronic myeloid leukemia. Cancer Genet. Cytogenet. 1985; 15: 17–24
   PubMed Web of Science ®Google Scholar
• Parreira L., Kearney L., Rassool F., Babapulle V. B., Mat-Utes E., Parreira A., Tavares de Castro J., Goldman J. M., Catovsky D. Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. Cancer Genet. Cytogenet. 1986; 22: 29–34
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Keating M. J., Talpaz M., Walters R. S., Smith T. L., Cork A., McCredie K. B., Freireich E. J. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am. J. Med. 1987; 83: 445–454
   PubMed Web of Science ®Google Scholar
• Ruff P., Saragas E., Poulos M., Weaving A. Patterns of clonal evolution in transformed chronic myelogenous leukemia. Cancer Genet. Cyrogenet. 1995; 81: 182–184
   PubMed Web of Science ®Google Scholar
• Griesshammer M., Heinze B., Bangerter M., Heimpel H., Fliedner T. M. Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia. J. Mol. Med. 1997; 75: 836–838
   PubMed Web of Science ®Google Scholar
• Prigogina E. L., Fleischman E. W., Volkova M. A., Frenkel M. A. Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia. Hum. Genet. 1978; 41: 143–156
   PubMed Web of Science ®Google Scholar
• Sokal J. E., Cox E. B., Baccarini M., Tura S., Gomez G. A., Robertson J. E., Italian Cooperative CML Study Group. Prognostic discrimination in “good risk” chronic granulocytic leukemia. Blood 1984; 63: 789–799
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman M., Rosell J., Urbano-lspizua A., Montserrat E., Rozman C. A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia. Br. J. Haematol. 1990; 76: 27–32
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Dixon D., Keating M. J., Talpaz M., Walten R. S., McCredie K. B., Freireich E. J. Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer 1988; 61: 1441–1446
   PubMed Web of Science ®Google Scholar
• Cervantes F., López-Guillermo A., Bosch F., Terol M. J., Rozman C., Montserrat E. An assessment of the clinicohaematological criteria for the accelerated phase of chronic myeloid leukaemia. Eur J. Haematol. 1996; 57: 286–291
   PubMed Web of Science ®Google Scholar
• Urbano-Ispizua A., Cervantes F., Matutes E., Villamor N., Pujades A., Sierra J., Feliu E., Vives-Corrons J. L., Montserrat E., Rozman C. Immunophenotypic characteristics of blast crisis of chronic myeloid leukemia: correlations with clinico-biological features and survival. Leukemia 1993; 7: 1349–1354
   PubMed Web of Science ®Google Scholar
• Mitelman F. An International System for Human Cytogenetic Nomenclature. Karger, Basel 1995
   Google Scholar
• Kaplan G., Meier P. Nonparametric estimation for incomplete observations. J. Am. Stat. Assor. 1985; 53: 457–463
   Google Scholar
• Mercer W. E., Arignolo C., Baserga R. Role of the p53 protein in cell proliferation as studied by microinjec-tion of monoclonal antibodies. Moll. Cell. Biol. 1984; 4: 276–281
   PubMed Web of Science ®Google Scholar
• Imamura J., Miyoshi 1., Koeffler P. p53 in hematologic malignancies. Blood 1994; 84: 2412–2421
   PubMed Web of Science ®Google Scholar
• Fioretos T., Strömbeck B., Sandberg T., Johansson B., Bill-strom R., Borg A., Nilsson P., Van Den Berghe H., Hagemeijer A., Mitelman F., Hoglund M. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17pl l and is not associated with coding TP53 mutations. Blood 1999; 94: 225–232
   PubMed Web of Science ®Google Scholar
• Fenaux P. The clinical significance of mutations of the p53 tumour suppressor gene in haematological malignancies. BE J. Haematol. 1997; 98: 502–511
   PubMed Web of Science ®Google Scholar
• Sonta S., Sandberg A. A. Chromosomes and causation of human cancer and leukemia. XXIX. Further studies on karyotypic progression in CML. Cancer 1978; 41: 153–163
   PubMed Web of Science ®Google Scholar